YY1 Multimerization Peptides for Enhancer-Promoter Loop Disruption

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current understanding of proteins facilitating structural interactions between enhancers and promoters is limited, particularly regarding the mechanisms of enhancer-promoter interactions and their role in gene regulation.

Innovation Solution

The transcription factor YY1 is demonstrated to structure looping interactions between enhancers and promoters through multimerization, and methods are developed to modulate gene expression by manipulating YY1's multimerization, thereby affecting enhancer-promoter DNA loop formation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If transcription factor multimerization is utilized to structure enhancer-promoter loops, then gene expression control is achieved, but the mechanism is poorly understood and difficult to manipulate

Engineering Contradiction:
Improvegene expression controlVSAvoidmechanism complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent introduces peptides that specifically bind to transcription factor multimers as intermediary molecules. These peptides disrupt the multimerization of transcription factors bound at enhancers and promoters, thereby disrupting enhancer-promoter looping interactions. This intermediary approach provides a controllable mechanism to modulate gene expression by interfering with the protein-protein interactions that structure chromatin loops.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Adaptability or versatility

If YY1 multimerization is disrupted to modulate gene expression, then enhancer-promoter loop formation is affected, but specificity of target gene identification becomes challenging

Engineering Contradiction:
Improvegene expression modulationVSAvoidenhancer-promoter specificity
Core Design Contradiction:
Adaptability or versatilityVSMeasurement precision

Solution Approach 1:

The patent employs peptides with specific binding characteristics that target particular transcription factor multimers at specific genomic locations. By designing peptides that bind to YY1 multimers formed at specific enhancer-promoter interfaces, the method achieves localized disruption of looping interactions. This local quality approach allows selective modulation of specific gene expression programs while maintaining specificity in identifying target enhancer-promoter pairs.

Inventive Principle:
Principle #3Local quality

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach allows for the modulation of gene expression and treatment of diseases associated with aberrant gene expression, such as cancer, by disrupting or enhancing enhancer-promoter loops dependent on YY1 binding, providing a mechanism to identify target genes and determine enhancer-promoter specificity.

Implementation Method 1

YY1 may structure enhancer-promoter loops by the multimerization (e.g., dimerization) of YY1 molecules bound at two distant DNA elements

Methodology Applied
Scientific EffectMultimerization:

Implementation Method 2

transcription factors (TFs) bind these enhancer elements and regulate transcription from the promoters of nearby or distant genes through physical contacts that involve looping of DNA between enhancers and promoters

Methodology Applied
Scientific EffectDNA looping:

Implementation Method 3

Transcription factors (TFs) bind these enhancer elements and regulate transcription from the promoters of nearby or distant genes

Methodology Applied
Scientific EffectTranscription factor binding:

Data Source

PatentUS20240263184A1Methods of altering gene expression by perturbing transcription factor multimers that structure regulatory loops
Publication Date: 2024.08.08 WHITEHEAD INST FOR BIOMEDICAL RES
  • US20240263184A1 patent drawing
  • US20240263184A1 patent drawing
  • US20240263184A1 patent drawing

AI summary

The invention relates to methods of modulating the expression of one or more genes in a cell by modulating the multimerization of a transcription factor and/or modulating the formation of enhancer-promoter DNA loops, and thereby modulating the expression of the one or more genes. The invention also relates to treating diseases and conditions involving aberrant gene expression by modulating the multimerization of a transcription factor and/or modulating the formation of enhancer-promoter DNA loops. The invention also relates to methods for screening for compounds that modulate expression of one or more genes in a cell.